Zobrazeno 31 - 40
of 117
pro vyhledávání: '"Ana Gleisner"'
Publikováno v:
J Nephrol Ther
Renal dysfunction is a common comorbidity in patients with liver failure and is a well-established predictor of both morbidity and mortality among patients awaiting liver transplantation. The etiology of renal failure in patients with cirrhosis can b
Autor:
Sarah Lindsey Davis, Swati G. Patel, Amy Walde, William T. Purcell, Patrick J. Blatchford, Rebekah Anders, Megan D. Marsh, Cheryl Meguid, Christopher H. Lieu, Steven A. Ahrendt, Elisa H. Birnbaum, Gurprataap S. Sandhu, Stephen Leong, Wells A. Messersmith, Karyn A. Goodman, Ana Gleisner, Richard D. Schulick, Jon D. Vogel, Gentry Teng King, Tracey E. Schefter, Reed Weiss, Matthew A. Brown, Alexis D. Leal, Michelle L. Cowan, Marco Del Chiaro, Whitney Herter, Martin D. McCarter
Publikováno v:
Colorectal Cancer. 9
Background: We examined characteristics of early-onset colorectal cancer (CRC) patients to identified factors, which may lead to earlier diagnosis. Materials & methods: This is a retrospective study with inclusion criteria: CRC diagnosed between 2012
Outcomes After Converted Minimally Invasive to Open Esophagectomy in Patients With Esophageal Cancer
Autor:
Robert A. Meguid, Laura Helmkamp, Christopher D. Scott, Allana M. White, Ana Gleisner, Alison L. Halpern, Anna K. Gergen, Michael J. Weyant, Robert J. Torphy, Martin D. McCarter, John D. Mitchell
Publikováno v:
The Annals of thoracic surgery. 112(5)
Background The objective of this study was to evaluate the impact of unplanned conversion to open esophagectomy during minimally invasive esophagectomy (MIE) on postoperative morbidity and mortality for patients with esophageal cancer, as well as to
Autor:
Karyn A. Goodman, Felix Ho, Tracey E. Schefter, Michael J. Weyant, John D. Mitchell, Robert J. Torphy, Sunnie Kim, Sachin Wani, Stephen Leong, Chloe Friedman, Robert A. Meguid, Christopher D Scott, Martin D. McCarter, Ana Gleisner
Publikováno v:
Ann Surg Oncol
BACKGROUND: Neoadjuvant chemotherapy with concurrent radiotherapy (nCRT) is an accepted treatment regimen for patients with potentially curable esophageal and gastroesophageal junction (GEJ) adenocarcinoma. The purpose of this study was to evaluate i
Autor:
Benedetto, Mungo, Chiara, Croce, Atsushi, Oba, Steven, Ahrendt, Ana, Gleisner, Chloe, Friedman, Richard D, Schulick, Marco, Del Chiaro
Publikováno v:
Annals of surgical oncology. 28(3)
Adjuvant chemotherapy and/or chemoradiation [chemo(radiation)] is considered the standard of care for resected patients with pancreatic adenocarcinoma. However, invasive carcinoma arising from an intraductal papillary mucinous neoplasm (IPMN) seems t
Autor:
Atsushi, Oba, Chiara, Croce, Patrick, Hosokawa, Cheryl, Meguid, Robert J, Torphy, Mohammed H, Al-Musawi, Steven, Ahrendt, Ana, Gleisner, Richard D, Schulick, Marco, Del Chiaro
Publikováno v:
Annals of surgery. 275(1)
To identify objective preoperative prognostic factors that are able to predict long-term survival of patients affected by PDAC.In the modern era of improved systemic chemotherapy for PDAC, tumor biology, and response to chemotherapy are essential in
Publikováno v:
Journal of Pancreatic Cancer, Vol 4, Iss 1, Pp 25-29 (2018)
Journal of Pancreatic Cancer
Journal of Pancreatic Cancer
Background: Solid pseudopapillary neoplasm of pancreas is a rare tumor with a low potential for metastasis and recurrence. Long-term outcomes after surgical resection are excellent and recurrences after an R0 resection are extremely rare. Case Presen
Autor:
Brandon C. Chapman, Richard D. Schulick, Martin D. McCarter, Brian C. Brauer, Karyn A. Goodman, Ana Gleisner, Csaba Gajdos, Devin Rigg, Cheryl Meguid, Barish H. Edil
Publikováno v:
Journal of Surgical Oncology. 117:1073-1083
Background and objectives To compare outcomes in patients receiving neoadjuvant stereotactic body radiation therapy (SBRT) with those receiving intensity-modulated radiation therapy (IMRT) for pancreatic adenocarcinoma. Methods We analyzed patients r
Autor:
Sarah E. Tevis, Jocelyn Johnson, Amber M. Moyer, Brianna Smalley, Camille L. Stewart, Marco Del Chiaro, Ana Gleisner, Christopher H. Lieu, Helen J. Madsen
Publikováno v:
Journal of the American College of Surgeons. 233:S237
Autor:
Patrick Hosokawa, Regina J. Brown, Christina Finlayson, Alicia A. Heelan Gladden, Ana Gleisner, David W. Mathes, Colleen Murphy, Tae W. Chong, Nicole Kounalakis, Sharon Sams
Publikováno v:
The American Journal of Surgery. 214:1104-1109
Background In 2014, SSO-ASTRO published guidelines which recommended “no ink on tumor” as adequate margins for patients undergoing breast conservation for invasive breast cancer. In 2016, new SSO-ASTRO-ASCO guidelines recommended 2 mm margins for